SS
Shivam Sagar Salgaocar
About Shivam Sagar Salgaocar
Data last updated:
Shivam Sagar Salgaocar is a Director at Geno Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Geno Pharmaceuticals Private Limited reported revenue of ₹349 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Oct 2023 | 1975 | ₹349 Cr (FY 2025) | Active |
Board colleagues of Shivam Sagar Salgaocar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dilip Salgaocar Ramacrisna | 00044240 | Geno Pharmaceuticals Private Limited | Director |
| Pallavi Sagar Salgaocar | 00044805 | Geno Pharmaceuticals Private Limited | Whole-Time Director |
| Pramod Dilip Salgaocar | 00044595 | Geno Pharmaceuticals Private Limited | Whole-Time Director |
| Sagar Dilip Salgaocar | 00044689 | Geno Pharmaceuticals Private Limited | Managing Director |
| Suriakiran Umacanta Sinaikunde | 06960059 | Geno Pharmaceuticals Private Limited | Director |
| Teja Mahesh Gadekar | Geno Pharmaceuticals Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shivam Sagar Salgaocar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shivam Sagar Salgaocar
Shivam Sagar Salgaocar currently holds 1 directorship: Geno Pharmaceuticals Private Limited (Director, since 23 Oct 2023, revenue ₹349 Cr (FY 2025)).
Shivam Sagar Salgaocar was first appointed on 23 Oct 2023 as Director at Geno Pharmaceuticals Private Limited.
The current boards of Shivam Sagar Salgaocar's companies include Dilip Salgaocar Ramacrisna (Geno Pharmaceuticals Private Limited), Pallavi Sagar Salgaocar (Geno Pharmaceuticals Private Limited), Pramod Dilip Salgaocar (Geno Pharmaceuticals Private Limited), Sagar Dilip Salgaocar (Geno Pharmaceuticals Private Limited), Suriakiran Umacanta Sinaikunde (Geno Pharmaceuticals Private Limited), Teja Mahesh Gadekar (Geno Pharmaceuticals Private Limited).